SQA
HQL

Simon Quick Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

Simon Quick Advisors’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-300
Closed -$5K – 456
2021
Q1 		$5K Buy
+300
New +$6.18K ﹤0.01% 416

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
MC
Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Simon Quick Advisors's HQL Position: Q2 2021 in Review

Simon Quick Advisors sold out of abrdn Life Sciences Investors (HQL) in Q2 2021, closing a stake of 300 shares — an estimated $5K sold.

Simon Quick Advisors first reported a position in HQL in Q1 2021 and held it in 1 quarter. The position peaked at $5K in Q1 2021. 67 funds tracked by Wall St. Rank hold HQL as of Q2 2021.

  • Simon Quick Advisors reported no remaining abrdn Life Sciences Investors position as of Q2 2021 after selling out during the quarter.
  • Simon Quick Advisors sold 300 abrdn Life Sciences Investors shares in Q2 2021, an estimated $5K.
  • Simon Quick Advisors first reported a position in abrdn Life Sciences Investors in Q1 2021 and held it in 1 quarter.
  • Simon Quick Advisors's abrdn Life Sciences Investors position peaked at $5K in Q1 2021.
  • 67 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2021.

Based on Simon Quick Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.